PIN/DLC8 Antibody (13C9) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59394JF669
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 13C9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human PIN/DLC8 (1-89aa) purified from E. coli
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for PIN/DLC8 Antibody (13C9) [Janelia Fluor® 669]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PIN
Long Name
Protein Inhibitor of Neuronal Nitric Oxide Synthase
Alternate Names
DLC1, DLC8, DNCL1, DNCLC1, DYNLL1, LC8a
Gene Symbol
DYNLL1
Additional PIN Products
Product Documents for PIN/DLC8 Antibody (13C9) [Janelia Fluor® 669]
Product Specific Notices for PIN/DLC8 Antibody (13C9) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...